Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Fortune India
39m
$18.8 billion pre-IPO shares of 43 stocks set to escape lock-up in Oct-Dec
The 1-month lock-in period will expire for 11 stocks, including Bajaj Housing Finance, Diffusion Engineers, Tolins Tyres, ...
40m
on MSN
Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Tickets to climb to $5
Milton becomes Category 5
American sentenced in RU
Ranger dies during rescue
Musk's X appeal rejected
Vanderbilt, Arkansas fined
Richest female musician
Human life expectancy study
Grammy-winning singer dies
Supreme Court rejects bid
US overdose deaths drop
Targeted by a cyberattack
King named grand marshal
Hamas strikes Tel Aviv
Names new school board
Ordered to open app store
R. Kelly's appeal declined
North Dakota wildfires
TX emergency abortion case
Another top aide resigns
GA abortion ban reinstated
NC voting rule changes
Ukraine strikes RU oil hub
Hamas backers sanctioned
Faces assault, drug charges
Record military aid to Israel
Launches asteroid probe
IVF clinic's appeal rejected
US antitrust case advances
Related topics
Supreme Court of the United States
Martin Shkreli
Pfizer
Indian rupee
Natco
Feedback